Impact of<sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial

Our rationale was to investigate whether <sup>18</sup>F-FDG PET/MRI in addition to (guideline-recommended) conventional staging leads to changes in therapeutic management in patients with newly diagnosed breast cancer and compare the diagnostic accuracy of <sup>18</sup>F-FDG PET/MRI with that of conventional staging for determining the Union for International Cancer Control (UICC) stage. <b>Methods:</b> In this prospective, double-center study, 208 women with newly diagnosed, therapy-naïve invasive breast cancer were enrolled in accordance with the inclusion criteria. All patients underwent guideline-recommended conventional staging and whole-body <sup>18</sup>F-FDG PET/MRI with a dedicated breast examination. A multidisciplinary tumor board served to determine 2 different therapy recommendations for each patient, one based on conventional staging alone and another based on combined assessment of conventional staging and <sup>18</sup>F-FDG PET/MRI examinations. Major changes in therapy recommendations and differences between the conventional staging algorithm and <sup>18</sup>F-FDG PET/MRI for determining the correct UICC stage were reported and evaluated. <b>Results:</b> Major changes in therapeutic management based on combined assessment of conventional staging and <sup>18</sup>F-FDG PET/MRI were detected in 5 of 208 patients, amounting to changes in therapeutic management in 2.4% (95% CI, 0.78%-5.2%) of the study population. In determining the UICC stage, the guideline-based staging algorithm and <sup>18</sup>F-FDG PET/MRI were concordant in 135 of 208 (64.9%; 95% CI, 58%-71.4%) patients. The conventional guideline algorithm correctly determined the UICC stage in 130 of 208 (62.5%; 95% CI, 55.5%-69.1%) patients, and <sup>18</sup>F-FDG PET/MRI correctly determined the UICC stage in 170 of 208 (81.9%; 95% CI, 75.8%-86.7%) patients. <b>Conclusion:</b> Despite the diagnostic superiority of <sup>18</sup>F-FDG PET/MRI over conventional staging in determining the correct UICC stage, the current (guideline-recommended) conventional staging algorithm is sufficient for adequate therapeutic management of patients with newly diagnosed breast cancer, and <sup>18</sup>F-FDG PET/MRI does not have an impact on patient management.

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2024-10-10
DOI
https://doi.org/10.2967/jnumed.124.268065
Primary Topic
Medical Imaging Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial

Julian Kirchner, Nils Martin Bruckmann, Janna Morawitz, Christiane Matuschek et al.
Journal of Nuclear Medicine
Medical Imaging Techniques and Applications
article

Impact of18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial

Julian Kirchner, Nils Martin Bruckmann, Janna Morawitz, Christiane Matuschek, Svjetlana Mohrmann, Eugen Ruckhäberle, Werner Schmid, Lena Häberle, Lale Umutlu, Gerald Antoch, Wolfgang P. Fendler, Iréne Esposito, Kai Jannusch, Johannes Grueneisen, Martin Stuschke, Wilfried Budach, Andreas Stang, Ann‐Kathrin Bittner, Bernd Kowall, Oliver Hoffmann, Ken Herrmann, Christian Buchbender, Frederik Lars Giesel
article en

Abstract

Our rationale was to investigate whether <sup>18</sup>F-FDG PET/MRI in addition to (guideline-recommended) conventional staging leads to changes in therapeutic management in patients with newly diagnosed breast cancer and compare the diagnostic accuracy of <sup>18</sup>F-FDG PET/MRI with that of conventional staging for determining the Union for International Cancer Control (UICC) stage. <b>Methods:</b> In this prospective, double-center study, 208 women with newly diagnosed, therapy-naïve invasive breast cancer were enrolled in accordance with the inclusion criteria. All patients underwent guideline-recommended conventional staging and whole-body <sup>18</sup>F-FDG PET/MRI with a dedicated breast examination. A multidisciplinary tumor board served to determine 2 different therapy recommendations for each patient, one based on conventional staging alone and another based on combined assessment of conventional staging and <sup>18</sup>F-FDG PET/MRI examinations. Major changes in therapy recommendations and differences between the conventional staging algorithm and <sup>18</sup>F-FDG PET/MRI for determining the correct UICC stage were reported and evaluated. <b>Results:</b> Major changes in therapeutic management based on combined assessment of conventional staging and <sup>18</sup>F-FDG PET/MRI were detected in 5 of 208 patients, amounting to changes in therapeutic management in 2.4% (95% CI, 0.78%-5.2%) of the study population. In determining the UICC stage, the guideline-based staging algorithm and <sup>18</sup>F-FDG PET/MRI were concordant in 135 of 208 (64.9%; 95% CI, 58%-71.4%) patients. The conventional guideline algorithm correctly determined the UICC stage in 130 of 208 (62.5%; 95% CI, 55.5%-69.1%) patients, and <sup>18</sup>F-FDG PET/MRI correctly determined the UICC stage in 170 of 208 (81.9%; 95% CI, 75.8%-86.7%) patients. <b>Conclusion:</b> Despite the diagnostic superiority of <sup>18</sup>F-FDG PET/MRI over conventional staging in determining the correct UICC stage, the current (guideline-recommended) conventional staging algorithm is sufficient for adequate therapeutic management of patients with newly diagnosed breast cancer, and <sup>18</sup>F-FDG PET/MRI does not have an impact on patient management.

Journal of Nuclear MedicineVol. 65(12)
Zimmer Biomet (Netherlands) (NL), Düsseldorf University Hospital (DE), Essen University Hospital (DE), West German Heart and Vascular Center Essen (DE), Deutsches Konsortium für Translationale Krebsforschung (DE), Heinrich Heine University Düsseldorf (DE), University of Duisburg-Essen (DE)
Openalex Percentile: Top 70%
Medical Imaging Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.